| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1018724531 |
| P356 | DOI | 10.2165/00023210-200115100-00005 |
| P698 | PubMed publication ID | 11602005 |
| P2093 | author name string | Halbreich U | |
| Kahn LS | |||
| P2860 | cites work | Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 |
| The Zurich Study. XII. Sex differences in depression. Evidence from longitudinal epidemiological data | Q33212784 | ||
| NAMS/Solvay Resident Essay Award. Relationship between estrogen, serotonin, and depression | Q33547425 | ||
| Effects of gonadal steroids in women with a history of postpartum depression | Q33903674 | ||
| Is premenstrual dysphoric disorder a distinct clinical entity? | Q33934979 | ||
| Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial | Q33949372 | ||
| Enhancing pharmacologic effects in the treatment of depression in women | Q33990845 | ||
| Transdermal delivery of drugs for the treatment of bone diseases | Q34017627 | ||
| Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause | Q34051384 | ||
| Insomnia and psychotropic drug consumption | Q34058241 | ||
| Questionable prescribing for elderly patients in Quebec. | Q34276987 | ||
| Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study | Q34286826 | ||
| Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. | Q34310007 | ||
| Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence | Q34349130 | ||
| Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome | Q34452948 | ||
| Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats | Q34564472 | ||
| Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group | Q34743026 | ||
| HRT: developments in therapy | Q35543142 | ||
| Is oestrogen therapy effective in the treatment of menopausal depression? | Q35983482 | ||
| Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication | Q36064075 | ||
| Non-genomic and genomic effects of steroids on neural activity | Q37773155 | ||
| Ovarian steroids and the brain: implications for cognition and aging | Q38464044 | ||
| Reproductive factors affecting the course of affective illness in women | Q38621336 | ||
| Clinically relevant basic science studies of gender differences and sex hormone effects. | Q48358379 | ||
| Psychoneuroendocrinology of depression. Hypothalamic-pituitary-gonadal axis | Q48427598 | ||
| Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. | Q48459426 | ||
| Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression | Q48778403 | ||
| A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters | Q49137222 | ||
| Gonadal hormones, reproductive age, and women with depression | Q49156194 | ||
| Alteration in the hypothalamic-pituitary-ovarian axis in depressed women | Q49156226 | ||
| Pubertal changes in hormone levels and depression in girls. | Q50654263 | ||
| Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. | Q50856088 | ||
| Estrogen-serotonin interactions: implications for affective regulation. | Q50858412 | ||
| Is the course of panic disorder the same in women and men? | Q50889174 | ||
| Gender differences, but no racial group differences, in self-reported psychiatric symptoms in adolescents. | Q50992314 | ||
| Use of medicines in general practice | Q51021822 | ||
| Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder. | Q51088263 | ||
| Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? | Q51093983 | ||
| Sex differences in recurrent depression: are there any that are significant? | Q51191710 | ||
| Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders. | Q51235577 | ||
| The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. | Q51252164 | ||
| The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors | Q39238416 | ||
| Estradiol-delivering vaginal rings for hormone replacement therapy | Q39434008 | ||
| Quality of life during sequential hormone replacement therapy -- a placebo-controlled study | Q39477086 | ||
| Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study | Q39495316 | ||
| Estrogen use and depressive symptoms in postmenopausal women | Q39500987 | ||
| Ineffectiveness of progesterone suppository treatment for premenstrual syndrome | Q39515990 | ||
| Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study | Q39555785 | ||
| Oestrogen therapy and the menopausal syndrome | Q39582567 | ||
| Sex Differences and the Epidemiology of Depression | Q39617578 | ||
| The epidemiology and social impact of premenstrual symptoms | Q39662318 | ||
| The effect of exogenous oestrogens on depression in menopausal women | Q40093532 | ||
| The role of oestrogen replacement in the climacteric syndrome | Q40120087 | ||
| Estrogen Therapy for Severe Persistent Depressions in Women | Q40222080 | ||
| The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. | Q40496639 | ||
| The multiple interactional biological processes that might lead to depression and gender differences in its appearance | Q40620529 | ||
| Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults | Q40745824 | ||
| The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women | Q40806348 | ||
| Assessing unipolar mood disorders in women | Q40836648 | ||
| Prevalence of mental disorders and psychosocial impairments in adolescents and young adults | Q40868504 | ||
| Altered serotonergic activity in women with dysphoric premenstrual syndromes | Q40918717 | ||
| Menstrually related disorders: what we do know, what we only believe that we know, and what we know that we do not know | Q40958899 | ||
| The clinical picture of the depressed form of puerperal psychosis | Q41358215 | ||
| The perimenopause and affective disorders | Q41379060 | ||
| Early onset (under age 30 years) and panic disorder as markers for etiologic homogeneity in major depression | Q41445623 | ||
| Role of estrogen in postmenopausal depression | Q41471933 | ||
| The role of estrogen in the treatment of Alzheimer's disease | Q41471952 | ||
| The influence of estrogen on monoamine oxidase activity. | Q41538402 | ||
| The association between premenstrual dysphoric disorder and other mood disorders | Q41680548 | ||
| The Myth of Involutional Melancholia | Q41693381 | ||
| Menstrually related disorders--towards interdisciplinary international diagnostic criteria | Q41718908 | ||
| Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats | Q42436381 | ||
| The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats | Q42484928 | ||
| Nonpsychotic postpartum depression among adolescent mothers | Q43454331 | ||
| Premenstrual changes. Impaired hormonal homeostasis. | Q43686194 | ||
| Sex steroids and affect in the surgical menopause: a double-blind, cross-over study | Q44040412 | ||
| Puberty and depression: the roles of age, pubertal status and pubertal timing | Q44075236 | ||
| The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment | Q44339393 | ||
| The identification and validation of distinct depressive syndromes in a population-based sample of female twins | Q44494810 | ||
| Gender differences in treatment response to sertraline versus imipramine in chronic depression | Q44875491 | ||
| Direction of weight change in recurrent depression. Consistency across episodes | Q44934689 | ||
| Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints | Q44941780 | ||
| Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. | Q44954107 | ||
| Gender differences in presentation of chronic major depression. | Q45100147 | ||
| Premenstrual Affective Syndrome and Affective Disorder | Q45144122 | ||
| Affective disorders in five United States communities | Q46057145 | ||
| Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group | Q46176549 | ||
| Estrogen improves psychological function in asymptomatic postmenopausal women | Q46492621 | ||
| Screening for post-partum depression in a community sample | Q47206116 | ||
| Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications | Q47717716 | ||
| Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity | Q47794553 | ||
| Cross-national epidemiology of major depression and bipolar disorder | Q47826731 | ||
| Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. | Q48124413 | ||
| Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain | Q48135017 | ||
| Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks | Q48238616 | ||
| 5-Hydroxytryptamine-mediated behaviour in male and female rats | Q48324460 | ||
| Effect of oestrogen on the sleep, mood, and anxiety of menopausal women | Q51283881 | ||
| Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. | Q51987358 | ||
| Hormone measures in reproductive endocrine-related mood disorders: diagnostic issues. | Q51989943 | ||
| Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. | Q52012028 | ||
| The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. | Q52039269 | ||
| Treatment of premenstrual dysphoria with alprazolam. A controlled study. | Q52058623 | ||
| Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). | Q52061362 | ||
| Characteristics of women seeking treatment for premenstrual syndrome. | Q52067183 | ||
| Acute psychiatric admission related to the menstrual cycle. | Q52092014 | ||
| The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. | Q52093717 | ||
| Sexual histories and premenstrual affective syndrome in psychiatric inpatients. | Q52097501 | ||
| Prospective study of the psychiatric disorders of childbirth. | Q52099316 | ||
| Premenstrual affective syndrome and psychiatric disorder | Q52112720 | ||
| Effect of exogenous oestrogens on minor psychiatric symptoms in postmenopausal women. | Q52117382 | ||
| Psychologic distress during menopause: associations across the reproductive life cycle. | Q52885163 | ||
| Sedative-hypnotic drug use in Canada. | Q53401319 | ||
| The effects of oestrogen therapy on the sex life of post-menopausal women | Q53898294 | ||
| Relationship of dysphoric premenstrual changes to depressive disorders. | Q54040131 | ||
| Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. | Q54451326 | ||
| Effects of iproniazid in depressive syndromes. | Q55477440 | ||
| Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting | Q55717918 | ||
| Effect of oestradiol on postpartum depression | Q60043583 | ||
| Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet α2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity | Q61480100 | ||
| Variations in the Taylor MAS of women with pre-menstrual syndrome | Q67014166 | ||
| Premenstrual symptoms and depression in a university population | Q67713858 | ||
| Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes | Q67763663 | ||
| Clinical significance of premenstrual dysphoric changes | Q67980787 | ||
| Vulnerability of postpartum depression: a prospective multivariate study | Q67990711 | ||
| Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder | Q68435975 | ||
| Estimating psychiatric morbidity by logistic regression: application to post-natal depression in a community sample | Q68596724 | ||
| Late luteal phase dysphoric disorder in young women | Q68610053 | ||
| Further psychometric evaluation of older women--the effect of estrogen administration | Q68614481 | ||
| An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients | Q68708069 | ||
| Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women | Q68717286 | ||
| Gender differences in the clinical features of unipolar major depressive disorder | Q68717726 | ||
| Thyrotropin and prolactin responses to thyrotropin-releasing hormone in premenstrual syndrome | Q69178101 | ||
| Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone | Q69373971 | ||
| Premenstrual exacerbation of binge eating in bulimia | Q69462139 | ||
| Thyroid hypofunction in premenstrual syndrome | Q69670988 | ||
| Spectral analysis of cyclic symptoms in late luteal phase dysphoric disorder | Q69689777 | ||
| Premenstrual changes and changes in gonadal hormones | Q69771425 | ||
| Effect of oestrogen and testosterone implants on psychological disorders in the climacteric | Q69893354 | ||
| Premenstrual relapse of puerperal psychosis | Q70057017 | ||
| Biologic effects of transdermal estradiol | Q70140885 | ||
| Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration | Q70275929 | ||
| TSH and prolactin responses to TRH in patients with premenstrual syndrome | Q70334733 | ||
| The premenstrual syndrome. Effects of "medical ovariectomy" | Q70390971 | ||
| Sodium lactate infusion in late luteal phase dysphoric disorder | Q70639940 | ||
| Violent crime and the menstrual cycle | Q70649125 | ||
| Use of Edinburgh Postnatal Depression Scale in a North American population | Q70664589 | ||
| Onset of depressive psychiatric crises and the menstrual cycle | Q70674599 | ||
| Transdermal oestrogen for treatment of severe postnatal depression | Q70994924 | ||
| A prospective study of emotional disorders in childbearing women | Q71255639 | ||
| Depressive symptomatology in new mothers: a stress and coping perspective | Q71300815 | ||
| The development and validation of a predictive index for postpartum depression | Q71330044 | ||
| Bipolar manic-depressive psychoses: results of a genetic investigation | Q71438281 | ||
| Use of the Edinburgh Postnatal Depression Scale in a southern, rural population in the United States | Q71485982 | ||
| Sertraline in the treatment of premenstrual dysphoric disorder | Q71797755 | ||
| Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide | Q71839854 | ||
| Prevalene of perimenstrual symptoms | Q71840406 | ||
| A randomised comparison over 8 months of 100 μg and 200 μg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome | Q71951802 | ||
| Individual coping style and psychological attitudes during pregnancy and predict depression levels during pregnancy and during postpartum | Q72306266 | ||
| Estrogen augments serotonergic activity in postmenopausal women | Q72327387 | ||
| Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism | Q72575297 | ||
| Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes | Q72665036 | ||
| Screening women for high risk of postnatal depression | Q72880423 | ||
| Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women | Q72919540 | ||
| Assay for conjugated estrogens in tablets using fused-silica capillary gas chromatography | Q72920749 | ||
| Adolescent depression: window of (missed?) opportunity | Q73010641 | ||
| Bioavailability of estradiol from a new matrix and a conventional reservoir-type transdermal therapeutic system | Q73018038 | ||
| Fluoxetine efficacy in menopausal women with and without estrogen replacement | Q73061974 | ||
| Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause | Q73388147 | ||
| Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome | Q73899600 | ||
| Estrogen replacement in perimenopause-related depression: a preliminary report | Q74171998 | ||
| Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey | Q74564491 | ||
| A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group | Q77734411 | ||
| Estrogen therapy for depression in postmenopausal women | Q77948966 | ||
| THE PREVALENCE OF MENSTRUAL DISORDERS IN PSYCHIATRIC PATIENTS | Q78273427 | ||
| Psychotropic effects of hormonal replacement therapy | Q79955094 | ||
| PMS treatment approaches and progesterone therapy | Q93639021 | ||
| P433 | issue | 10 | |
| P921 | main subject | estrogen | Q277954 |
| P304 | page(s) | 797-817 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | Role of estrogen in the aetiology and treatment of mood disorders | |
| P478 | volume | 15 |
| Q44478455 | A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender |
| Q41449756 | Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study |
| Q44670372 | Antidepressant-like effect of flaxseed secoisolariciresinol diglycoside in ovariectomized mice subjected to unpredictable chronic stress |
| Q37463944 | Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States |
| Q37480270 | Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. |
| Q47733278 | Chronic treatment with estradiol restores depressive-like behaviors in female Wistar rats treated neonatally with clomipramine |
| Q36210979 | Considerations in the management of bipolar disorder in women |
| Q37163243 | Depression-like behavior of aged male and female mice is ameliorated with administration of testosterone or its metabolites |
| Q46158767 | Developmental associations between adolescent change in depressive symptoms and menstrual-cycle-phase-specific negative affect during early adulthood |
| Q37566350 | Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease |
| Q48564226 | Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women: a randomized double-blind, controlled study |
| Q36123416 | Effect of estrogen-serotonin interactions on mood and cognition |
| Q35047973 | Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause |
| Q28547748 | Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study |
| Q38423386 | Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms: a randomized trial |
| Q26865143 | Effects of hormone therapy on cognition and mood |
| Q35864182 | Effects of stimulation and blockade of d(2) receptor on depression-like behavior in ovariectomized female rats. |
| Q43286294 | Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats |
| Q46046661 | Effects of the LHRH antagonist Cetrorelix on the brain function in mice |
| Q35544192 | Endocrine intervention for transsexuals |
| Q50935606 | Estradiol and tryptophan depletion interact to modulate cognition in menopausal women. |
| Q35585729 | Estradiol effects on the dopamine transporter - protein levels, subcellular location, and function. |
| Q36745218 | Estradiol reduces anxiety- and depression-like behavior of aged female mice |
| Q37753320 | Estrogen in the limbic system |
| Q34272184 | Estrogens of multiple classes and their role in mental health disease mechanisms |
| Q47588125 | Exercise training effects on premenstrual distress and ovarian steroid hormones |
| Q33980902 | Future antidepressants: what is in the pipeline and what is missing? |
| Q44701019 | Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders |
| Q24657105 | Genetic, epigenetic and environmental impact on sex differences in social behavior |
| Q40822236 | Genetically predicted 17beta-estradiol, cognitive function and depressive symptoms in women: A Mendelian randomization in the Guangzhou Biobank Cohort Study. |
| Q46486278 | Gonadal steroid modulation of the limbic-hypothalamic- pituitary-adrenal (LHPA) axis is influenced by social status in female rhesus monkeys |
| Q45969311 | Health-related quality of life following surgical menopause and following gonadotrophin-releasing hormone analogue-induced pseudomenopause. |
| Q33880940 | Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences |
| Q39412184 | Hormone treatment for mood disorders in women |
| Q43267057 | Hormones in the treatment of depression |
| Q45237521 | Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression |
| Q45888689 | Influence of a physical fitness course on menstrual cycle characteristics |
| Q51778874 | Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression. |
| Q44733490 | Interaction between estrogens and antidepressants in the forced swimming test in rats. |
| Q57525754 | Moderation of Breastfeeding Effects on Adult Depression by Estrogen Receptor Gene Polymorphism |
| Q94561149 | Mood Profiling in Singapore: Cross-Cultural Validation and Potential Applications of Mood Profile Clusters |
| Q35987563 | Neonatal serotonin depletion alters behavioral responses to spatial change and novelty |
| Q24630024 | Neurobiological Underpinnings of the Estrogen - Mood Relationship |
| Q45374681 | Oestradiol modulation of serotonin reuptake transporter and serotonin metabolism in the brain of monkeys |
| Q37791238 | Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response? |
| Q35020115 | Oral contraceptive use and psychiatric disorders in a nationally representative sample of women |
| Q35142054 | Ovariectomy results in variable changes in nociception, mood and depression in adult female rats |
| Q26738552 | Perspective of Postpartum Depression Theories: A Narrative Literature Review |
| Q35445700 | Postmenopausal hormone use impact on emotion processing circuitry |
| Q46343309 | Predictors of response to sertraline in patients with major depression |
| Q47830790 | Premenstrual Syndrome Is Associated With a Higher Frequency of Female Sexual Difficulty and Sexual Distress. |
| Q43414393 | Premenstrual symptoms and luteal suicide attempts |
| Q36036726 | Progesterone attenuates depressive behavior of younger and older adult C57/BL6, wildtype, and progesterone receptor knockout mice |
| Q35847258 | Psychiatric disorders in older women |
| Q35450239 | Puberty and perimenopause: reproductive transitions and their implications for women's health. |
| Q34158499 | Reduced Sleep Spindle Activity in Early-Onset and Elevated Risk for Depression |
| Q46364759 | Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test. |
| Q36823064 | Region- and sex-specific modulation of anxiety behaviours in the rat. |
| Q43481209 | Self-reported health in adolescent girls varies according to the season and its relation to medication and hormonal contraception--a descriptive study |
| Q54958527 | Serum levels of GPER-1 in euthymic bipolar patients. |
| Q47836220 | Sex Hormones and Healthy Psychological Aging in Women. |
| Q40573415 | Sex differences in the genetic risk for alcoholism. |
| Q35174373 | Sex steroid hormones and the neural control of breathing |
| Q27349510 | Shuyu Capsules Relieve Premenstrual Syndrome Depression by Reducing 5-HT3AR and 5-HT3BR Expression in the Rat Brain |
| Q34184540 | Significant association of estrogen receptor binding site variation with bipolar disorder in females |
| Q33566271 | Social status modifies estradiol activation of sociosexual behavior in female rhesus monkeys |
| Q55333269 | Steroid Hormones and Their Action in Women's Brains: The Importance of Hormonal Balance. |
| Q48579219 | Stress-induced sensitization of the limbic system in ovariectomized rats is partly restored by cyclic 17beta-estradiol administration |
| Q37424806 | Tetratricopeptide repeat domain 9A modulates anxiety-like behavior in female mice |
| Q92403518 | The Role of Allopregnanolone in Pregnancy in Predicting Postpartum Anxiety Symptoms |
| Q51940636 | The fountain of mental youth. Search for homeostatic and adaptational hormonal processes. |
| Q36501521 | The relation between menarche and the age of first symptoms in a multiple sclerosis cohort |
| Q35847263 | The role of estrogen in mood disorders in women |
| Q37385678 | The role of estrogen in the treatment of men with schizophrenia |
| Q35121756 | Trajectories of brain development: point of vulnerability or window of opportunity? |
| Q35798300 | Transdermal Estradiol Treatment for Postpartum Depression: A Pilot, Randomized Trial. |
| Q36134844 | Treatment of menopause-related mood disturbances. |
| Q46711723 | Upregulated mRNA levels of SERT, NET, MAOB, and BDNF in various brain regions of ovariectomized rats exposed to chronic aversive stimuli |
| Q26825947 | Using animal models to study post-partum psychiatric disorders |
Search more.